Jazan Omari

580 total citations
55 papers, 353 citations indexed

About

Jazan Omari is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jazan Omari has authored 55 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hepatology, 20 papers in Pulmonary and Respiratory Medicine and 14 papers in Surgery. Recurrent topics in Jazan Omari's work include Hepatocellular Carcinoma Treatment and Prognosis (24 papers), MRI in cancer diagnosis (11 papers) and Nutrition and Health in Aging (9 papers). Jazan Omari is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (24 papers), MRI in cancer diagnosis (11 papers) and Nutrition and Health in Aging (9 papers). Jazan Omari collaborates with scholars based in Germany, Poland and Netherlands. Jazan Omari's co-authors include Maciej Pech, Alexey Surov, Maciej Powerski, Andreas Wienke, Robert Damm, Borna Relja, Maximilian Thormann, Jens Ricke, Max Seidensticker and Frank Fischbach and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and International Journal of Cancer.

In The Last Decade

Jazan Omari

52 papers receiving 352 citations

Peers

Jazan Omari
Jeffrey Meier United States
Kyoung Min Moon South Korea
Seung Baek Hong South Korea
C. T. Germer Germany
Khaled Alkhawaldeh United States
Jeffrey Meier United States
Jazan Omari
Citations per year, relative to Jazan Omari Jazan Omari (= 1×) peers Jeffrey Meier

Countries citing papers authored by Jazan Omari

Since Specialization
Citations

This map shows the geographic impact of Jazan Omari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jazan Omari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jazan Omari more than expected).

Fields of papers citing papers by Jazan Omari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jazan Omari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jazan Omari. The network helps show where Jazan Omari may publish in the future.

Co-authorship network of co-authors of Jazan Omari

This figure shows the co-authorship network connecting the top 25 collaborators of Jazan Omari. A scholar is included among the top collaborators of Jazan Omari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jazan Omari. Jazan Omari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Omari, Jazan, et al.. (2025). Hepatic Hilar Nerve Block for Adjunctive Analgesia in Thermal Ablation of Liver Tumors: A Prospective Randomized Controlled Trial. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 197(12). 1426–1432. 1 indexed citations
2.
Fabritius, Matthias P., Benjamin Garlipp, Osman Öcal, et al.. (2024). Assessing regional hepatic function changes after hypertrophy induction by radioembolisation: comparison of gadoxetic acid-enhanced MRI and 99mTc-mebrofenin hepatobiliary scintigraphy. European Radiology Experimental. 8(1). 15–15. 1 indexed citations
3.
Damm, Robert, et al.. (2023). Parameters of body composition and creeping fat are associated with activity of Crohn's disease. Magnetic Resonance Imaging. 98. 1–6. 4 indexed citations
5.
Müller, Christian, Jazan Omari, Konrad Mohnike, et al.. (2023). Multidisciplinary Treatment of Patients with Progressive Biliary Tract Cancer after First-Line Gemcitabine and Cisplatin: A Single-Center Experience. Cancers. 15(9). 2598–2598. 3 indexed citations
6.
Thormann, Maximilian, et al.. (2023). Increase of radiologically determined muscle area in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt. Scientific Reports. 13(1). 17092–17092. 4 indexed citations
7.
Rak, Marko, et al.. (2023). Transfer-learning is a key ingredient to fast deep learning-based 4D liver MRI reconstruction. Scientific Reports. 13(1). 11227–11227. 5 indexed citations
8.
Omari, Jazan, et al.. (2022). Prevalence and role of low skeletal muscle mass (LSMM) in hepatocellular carcinoma. A systematic review and meta-analysis. Clinical Nutrition ESPEN. 49. 103–113. 17 indexed citations
9.
Thormann, Maximilian, et al.. (2022). A multimodal user interface for touchless control of robotic ultrasound. International Journal of Computer Assisted Radiology and Surgery. 18(8). 1429–1436. 11 indexed citations
10.
Thormann, Maximilian, Maciej Pech, Peter Hass, et al.. (2022). Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases. Journal of Contemporary Brachytherapy. 14(4). 364–369. 3 indexed citations
11.
Thormann, Maximilian, et al.. (2021). Impact of Pectoral Muscle Values on Clinical Outcomes in Patients With Severe Covid-19 Disease. In Vivo. 36(1). 375–380. 8 indexed citations
12.
Fabritius, Matthias P., F Hartmann, Ricarda Seidensticker, et al.. (2021). Liver Function Changes After Technetium-99m-Macroaggregated Albumin Administration and Their Predictive Value Regarding Hepatotoxicity in Patients Undergoing Yttrium-90-Radioembolization. Anticancer Research. 41(1). 437–444. 1 indexed citations
13.
Omari, Jazan, Robert Damm, Peter Hass, et al.. (2020). Interstitial Brachytherapy for Limited (<4 cm) and Large (≥4 cm) Hepatic Metastases from Rare and Less Common Cancers. Anticancer Research. 40(8). 4281–4289. 4 indexed citations
14.
Omari, Jazan, Peter Hass, Marino Venerito, et al.. (2019). Efficacy and safety of percutaneous computed tomography-guided high-dose-rate interstitial brachytherapy in treatment of oligometastatic lymph node metastases of retroperitoneal space. Journal of Contemporary Brachytherapy. 11(5). 436–442. 5 indexed citations
16.
Omari, Jazan, Robert Damm, Peter Hass, et al.. (2019). Radioablation of Hepatic Metastases from Renal Cell Carcinoma With Image-guided Interstitial Brachytherapy. Anticancer Research. 39(5). 2501–2508. 7 indexed citations
17.
Omari, Jazan, Peter Hass, Max Seidensticker, et al.. (2018). Image-guided Interstitial Brachytherapy in the Management of Metastasized Anal Squamous Cell Carcinoma. Anticancer Research. 38(9). 5401–5407. 3 indexed citations
18.
Omari, Jazan, Peter Hass, Max Seidensticker, et al.. (2018). Image-guided interstitial high-dose-rate brachytherapy in the treatment of metastatic esophageal squamous cell carcinoma. Journal of Contemporary Brachytherapy. 10(5). 439–445. 1 indexed citations
19.
Powerski, Maciej, Jazan Omari, Oliver S. Großer, et al.. (2018). Angiographic Anatomy and Relevance of 3 and 9 O’clock Arteries During Radioembolization. CardioVascular and Interventional Radiology. 41(6). 890–897. 1 indexed citations
20.
Omari, Jazan, Peter Hass, Max Seidensticker, et al.. (2018). Efficacy and safety of CT-guided high-dose-rate interstitial brachytherapy in primary and secondary malignancies of the pancreas. European Journal of Radiology. 112. 22–27. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026